The company has created a wearable medical device that uses vestibular masking technology to provide immediate relief of symptoms in approximately 80% of vertigo cases. Otolith Labs has received $1.8 million in contracts from the US Department of Defense to further develop the technology for their personnel needs. Their therapy utilizes a wearable headset that allows users to ignore undesired sensory information from their vestibular system, enabling users to mitigate the impact of vertigo and motion sickness. The company is a world-leader in vestibular masking technology and builds noninvasive wearable medical devices powered by science, data, and clinical research for the treatment of vertigo and vestibular disorders.